Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Weathers SP"'
Autor:
Majd NK; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Vo HH; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Moran CA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States., Weathers SP; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Song IW; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Williford GL; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Rodon J; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Fu S; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Tsimberidou AM; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Publikováno v:
The oncologist [Oncologist] 2024 Sep 06; Vol. 29 (9), pp. 811-816.
Autor:
Whisenant M; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Snyder S; Department of Psychology, School of Science, Indiana University-Purdue University at Indianapolis, Indianapolis, IN, USA., Weathers SP; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bruera E; Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Milbury K; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. kmilbury@mdanderson.org.
Publikováno v:
Journal of patient-reported outcomes [J Patient Rep Outcomes] 2024 Jul 17; Vol. 8 (1), pp. 74. Date of Electronic Publication: 2024 Jul 17.
Autor:
Lam K; Department of Neuro-Oncology, Unit 431, The University of Texas MD Anderson Cancer, 1400 Holcombe Blvd, Room FC7.3000, Houston, TX 77030, USA., Leung CH; Department of Biostatistics, The University of Texas MD Anderson Cancer, 1400 Pressler St, Houston, TX 77030, USA., Soomro Z; Department of Neuro-Oncology, Unit 431, The University of Texas MD Anderson Cancer, 1400 Holcombe Blvd, Room FC7.3000, Houston, TX 77030, USA., Wathoo C; Department of Neuro-Oncology, Unit 431, The University of Texas MD Anderson Cancer, 1400 Holcombe Blvd, Room FC7.3000, Houston, TX 77030, USA., Weathers SP; Department of Neuro-Oncology, Unit 431, The University of Texas MD Anderson Cancer, 1400 Holcombe Blvd, Room FC7.3000, Houston, TX 77030, USA.
Publikováno v:
CNS oncology [CNS Oncol] 2024 Jun 06; Vol. 13 (1), pp. 2352414. Date of Electronic Publication: 2024 May 28.
Autor:
Cho D; Department of Health Disparities Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Roth M; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Peterson SK; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Jennings K; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Kim S; The Center for Clinical Research and Evidence-Based Medicine, The University of Texas McGovern Medical School, Houston, TX, United States., Weathers SP; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ahmed S; Department of Lymphoma-Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Livingston JA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Barcenas C; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., You YN; Department of Colon & Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Milbury K; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Publikováno v:
JMIR research protocols [JMIR Res Protoc] 2024 Apr 23; Vol. 13, pp. e53307. Date of Electronic Publication: 2024 Apr 23.
Autor:
Gregory TA; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Neurology, Madigan Army Medical Center, Tacoma, Washington, USA., Knight SR; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Aaroe AE; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Highsmith KN; Department of Neuro-Oncology, Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Janatpour ZC; Department of Neurology, Madigan Army Medical Center, Tacoma, Washington, USA., O'Brien BJ; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Majd NK; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Loghin ME; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Patel CB; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Weathers SP; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Puduvalli VK; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kamiya-Matsuoka C; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Neuro-oncology practice [Neurooncol Pract] 2024 Apr 08; Vol. 11 (4), pp. 475-483. Date of Electronic Publication: 2024 Apr 08 (Print Publication: 2024).
Autor:
Nelson BE; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA. benelson1@mdanderson.org., Roszik J; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ahmed J; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Barretto CMN; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nardo M; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Campbell E; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Johnson AM; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Piha-Paul SA; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Oliva ICG; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Weathers SP; Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cabanillas M; Department of Endocrinology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Javle M; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Meric-Bernstam F; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Subbiah V; Early-Phase Drug Development, Sarah Cannon Research Institute, Nashville, TN, USA. Vivek.Subbiah@scri.com.
Publikováno v:
Molecular cancer [Mol Cancer] 2024 Mar 26; Vol. 23 (1), pp. 64. Date of Electronic Publication: 2024 Mar 26.
Autor:
Whisenant M; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Weathers SP; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Li Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Aldrich E; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ownby K; Cizik School of Nursing, The University of Texas Health Science Center at Houston, Houston, Texas, USA., Thomas J; Cizik School of Nursing, The University of Texas Health Science Center at Houston, Houston, Texas, USA., Ngo-Huang A; Department of Palliative, Rehabilitation, & Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Bruera E; Department of Palliative, Rehabilitation, & Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Milbury K; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Neuro-oncology practice [Neurooncol Pract] 2024 Mar 22; Vol. 11 (4), pp. 432-440. Date of Electronic Publication: 2024 Mar 22 (Print Publication: 2024).
Autor:
Gubbiotti MA; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Weinberg JS; Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Weathers SP; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Dasgupta P; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tom MC; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Aldape K; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Quezado M; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Abdullaev Z; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Huse JT; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ballester LY; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Journal of neuropathology and experimental neurology [J Neuropathol Exp Neurol] 2024 Jan 19; Vol. 83 (2), pp. 139-141.
Autor:
Nelson BE; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Reddy NK; Department of Internal Medicine, The University of Texas at Austin, Austin, TX, USA., Huse JT; Department of Pathology and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Amini B; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nardo M; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gouda M; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Weathers SP; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Subbiah V; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. viveksubbiah@outlook.com.; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. viveksubbiah@outlook.com.; MD Anderson Cancer Network, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. viveksubbiah@outlook.com.
Publikováno v:
NPJ precision oncology [NPJ Precis Oncol] 2023 May 25; Vol. 7 (1), pp. 47. Date of Electronic Publication: 2023 May 25.
Autor:
Gregory TA; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Mastall M; Department of Neurology, Clinical Neuroscience and Brain Tumor Center, University Hospital Zurich, Zurich, Switzerland., Lin H; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hess KR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yuan Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Martin-Bejarano Garcia M; Health Research Institute, Hospital Clinico San Carlos, Madrid, Spain., Fuller GN; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Alfaro KD; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gule-Monroe MK; Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Huse JT; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Khatua S; Department of Pediatric Neuro-Oncology, Mayo Clinic, Rochester, Minnesota, USA., Rao G; Department of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA., Sandberg DI; Department of Pediatric Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wefel JS; Department of Neuropsychology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yeboa DN; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Paulino AC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., McGovern SL; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Zaky W; Department of Pediatric Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Mahajan A; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA., Suki D; Department of Pediatric Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Weathers SP; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Harrison RA; Department of Neuro-Oncology, BC Cancer Agency Vancouver Centre, Vancouver, British Columbia, Canada., de Groot JF; Brain Tumor Center, UCSF Medical Center, San Francisco, California, USA., Puduvalli VK; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Penas-Prado M; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Majd NK; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Neuro-oncology advances [Neurooncol Adv] 2023 Apr 13; Vol. 5 (1), pp. vdad032. Date of Electronic Publication: 2023 Apr 13 (Print Publication: 2023).